GNH USA

Europe — EMA

Mononit 60 Retard (Isosorbide Mononitrate)

GNH USA supplies Mononit 60 Retard (Isosorbide Mononitrate), a nitrate vasodilator for angina prophylaxis and chronic stable angina. Request a quote today.

Request sourcing

1
Pack/s

What is Isosorbide Mononitrate?

Isosorbide Mononitrate, the active ingredient in Mononit 60 Retard, is a nitrate (vasodilator) presented as a 60 mg extended‑release tablet for oral use. It treats angina pectoris and chronic stable angina by improving myocardial oxygen supply.

GNH USA supplies Mononit 60 Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Isosorbide Mononitrate used for?

Isosorbide Mononitrate is employed in the management of coronary artery disease‑related angina. - Angina pectoris prophylaxis: reduces frequency of chest pain episodes in patients with established angina. - Chronic stable angina: improves exercise tolerance and decreases symptom burden during daily activities. - Exercise‑induced angina: helps prevent angina attacks triggered by physical exertion.

What are the side effects of Isosorbide Mononitrate?

Isosorbide Mononitrate may cause a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Headache: throbbing pain often occurring shortly after dosing. - Dizziness: light‑headed sensation, especially when standing quickly. - Flushing: warm, reddening of the face or neck. - Nausea: mild stomach upset or urge to vomit. - Hypotension: lower than normal blood pressure causing faintness.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure leading to syncope. - Reflex tachycardia: rapid heart rate in response to vasodilation. - Myocardial infarction: rare occurrence of heart attack. - Allergic reaction: rash, itching, swelling, or difficulty breathing.

What precautions apply to Isosorbide Mononitrate?

Before prescribing Mononit 60 Retard, clinicians should consider several precautionary measures to ensure safe use. - Assess cardiovascular status: evaluate blood pressure and heart rate prior to initiation. - Avoid concurrent PDE‑5 inhibitors: co‑administration can cause profound hypotension. - Monitor for tolerance development: efficacy may diminish with prolonged use. - Adjust dose in renal impairment: consider reduced dosing in patients with decreased renal function. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

What does Isosorbide Mononitrate interact with?

Isosorbide Mononitrate interacts with several drug classes; awareness of these interactions helps prevent adverse events.

Major Interactions (Avoid): - Sildenafil and other PDE‑5 inhibitors: may cause severe hypotension. - Other nitrates (e.g., nitroglycerin): additive vasodilatory effect leading to dangerous blood‑pressure drops. - Antihypertensive agents (e.g., ACE inhibitors, beta‑blockers): can enhance blood‑pressure‑lowering effects.

Moderate Interactions (Monitor Closely): - Diuretics: may increase risk of orthostatic hypotension. - Alcohol: can potentiate vasodilatory effects and dizziness. - Azole antifungals (e.g., ketoconazole): may raise plasma concentrations of isosorbide mononitrate.

Frequently asked questions

What is Mononit 60 Retard used for?+
Mononit 60 Retard contains isosorbide mononitrate, a nitrate vasodilator indicated for the prophylaxis of angina pectoris and for the treatment of chronic stable angina. It helps reduce the frequency of chest pain episodes and improves exercise tolerance in patients with coronary artery disease.
How does Isosorbide Mononitrate work?+
Isosorbide mononitrate is converted in the body to nitric oxide, which activates guanylate cyclase in vascular smooth muscle. The resulting rise in cyclic GMP relaxes arteries and veins, lowering preload and afterload, decreasing myocardial oxygen demand, and increasing coronary blood flow to relieve ischemic chest pain.
What is the usual dose of Mononit 60 Retard?+
The appropriate dose of Mononit 60 Retard is determined by the prescribing clinician based on the individual patient's condition, response, and tolerability. Physicians typically start with a low dose and may adjust it according to therapeutic goals and any side‑effects, but specific dosing regimens should not be assumed.
Is Mononit 60 Retard safe during pregnancy or breastfeeding?+
Safety data for isosorbide mononitrate in pregnancy and lactation are limited. The product should be used only if the potential benefit justifies any potential risk to the fetus or infant. Healthcare providers usually advise against routine use during pregnancy or breastfeeding unless absolutely necessary.
How do I order Mononit 60 Retard from GNH USA?+
To order Mononit 60 Retard, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.
How does Mononit 60 Retard compare with other anti‑anginal drugs?+
Mononit 60 Retard belongs to the nitrate class, which primarily reduces cardiac workload through vasodilation. Compared with beta‑blockers or calcium‑channel blockers, nitrates act more directly on vascular smooth muscle and are often used when other agents are insufficient or contraindicated. Each class has a distinct side‑effect profile, so choice depends on patient‑specific factors.
How should Mononit 60 Retard be stored?+
Mononit 60 Retard tablets should be stored at ambient temperature below 25 °C. Keep them in the original packaging, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain tablet integrity throughout its shelf life.
How is Mononit 60 Retard administered?+
Mononit 60 Retard is taken orally as an extended‑release tablet. The tablet should be swallowed whole with a glass of water and not chewed, crushed, or broken, as altering the tablet can affect the controlled‑release mechanism and increase the risk of side effects.
What are the most serious risks associated with Mononit 60 Retard?+
The most serious risks include severe hypotension, which can lead to fainting or shock, and rare allergic reactions that may cause rash, swelling, or breathing difficulties. Patients should seek immediate medical attention if they experience sudden drops in blood pressure, chest pain, or signs of an allergic response.
Who should not use Mononit 60 Retard?+
Mononit 60 Retard is contraindicated in patients with known hypersensitivity to isosorbide mononitrate or other nitrates, those taking phosphodiesterase‑5 inhibitors (e.g., sildenafil) due to the risk of profound hypotension, and individuals with severe hypotension or cardiogenic shock. Clinicians should review a patient’s medication list and medical history before prescribing.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Isosorbide Mononitrate
Route
Oral Use
Manufacturer
Sanofi Sp. Z O.O.
Origin
EU

Related products